• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在院前门户对无 ST 段抬高的胸痛患者进行快速评估和管理(FamouS Triage):用改良的 HEART 评分在家中排除心肌梗死。

Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score.

机构信息

1 Department of Cardiology, Isala Hospital, The Netherlands.

2 Department of Cardiology, University Hospital Coventry, UK.

出版信息

Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):102-110. doi: 10.1177/2048872616687116. Epub 2017 Jan 13.

DOI:10.1177/2048872616687116
PMID:28084079
Abstract

BACKGROUND

The first study of the FamouS Triage project investigates the feasibility of ruling out a myocardial infarction in pre-hospital chest pain patients without electrocardiographic ST-segment elevation by using the modified HEART score at the patient's home, incorporating only a single highly sensitive troponin T measurement.

METHODS

A venous blood sample was drawn in the ambulance from 1127 consecutive chest pain patients for measurement of the pre-hospital highly sensitive troponin T levels, in order to establish a pre-hospital HEART score (i.e. the modified HEART score) and evaluate the possibility of triage at the patient's home. The primary endpoint was the occurrence of a major adverse cardiac event (MACE) i.e. acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting or death within 30 days after initial presentation.

RESULTS

Two hundred and six patients (18%) developed a MACE during 30 days of follow-up. Thirty-six per cent of the patients ( n=403) had a low modified HEART score (0-3 points) and none of them developed a MACE during follow-up. Forty-four per cent of the patients ( n=494) had an intermediate modified HEART score (4-6 points) and 18% of them developed a MACE. Twenty per cent of the patients ( n=230) had a high modified HEART score (7-10 points) of which 52% developed a MACE during follow-up.

CONCLUSION

It seems feasible to rule out a myocardial infarction at home in chest pain patients without ST-segment elevation by using the modified HEART score.

TRIAL ID

NTR4205. Dutch Trial Register [ http://www.trialregister.nl ]: trial number 4205.

摘要

背景

FamouS Triage 项目的第一项研究旨在调查在院前胸痛患者中,通过在家中使用改良 HEART 评分(仅包含单次高敏肌钙蛋白 T 测量)来排除心电图 ST 段抬高型心肌梗死的可行性。

方法

从 1127 例连续胸痛患者的救护车上抽取静脉血样,用于测量院前高敏肌钙蛋白 T 水平,以建立院前 HEART 评分(即改良 HEART 评分)并评估在患者家中分诊的可能性。主要终点是 30 天内发生主要不良心脏事件(MACE)即急性心肌梗死、经皮冠状动脉介入治疗、冠状动脉旁路移植术或死亡。

结果

206 例患者(18%)在 30 天的随访中发生了 MACE。36%的患者(n=403)改良 HEART 评分低(0-3 分),且随访期间均未发生 MACE。44%的患者(n=494)改良 HEART 评分中等(4-6 分),18%发生了 MACE。20%的患者(n=230)改良 HEART 评分高(7-10 分),其中 52%在随访期间发生了 MACE。

结论

似乎可以通过使用改良 HEART 评分在家中排除无 ST 段抬高的胸痛患者的心肌梗死。

试验注册

NTR4205.荷兰试验注册中心[http://www.trialregister.nl]:试验编号 4205。

相似文献

1
Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score.在院前门户对无 ST 段抬高的胸痛患者进行快速评估和管理(FamouS Triage):用改良的 HEART 评分在家中排除心肌梗死。
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):102-110. doi: 10.1177/2048872616687116. Epub 2017 Jan 13.
2
Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: rationale and design.院前阶段对无ST段抬高型胸痛的快速评估与管理:原理与设计
Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):129-36. doi: 10.1177/2048872614549738. Epub 2014 Sep 8.
3
The HEART score in the era of the European Society of Cardiology 0/1-hour algorithm.欧洲心脏病学会 0/1 小时算法时代的 HEART 评分。
Eur Heart J Acute Cardiovasc Care. 2020 Feb;9(1):30-38. doi: 10.1177/2048872619883619. Epub 2019 Oct 28.
4
Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study.院前疑似非 ST 段抬高型急性冠状动脉综合征风险评估:一项前瞻性观察研究。
Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(1_suppl):5-12. doi: 10.1177/2048872618813846. Epub 2018 Nov 23.
5
Assessing sensitivity and specificity of the Manchester Triage System in the evaluation of acute coronary syndrome in adult patients in emergency care: a systematic review protocol.评估曼彻斯特分诊系统在急诊护理中评估成年急性冠状动脉综合征患者时的敏感性和特异性:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Nov;13(11):64-73. doi: 10.11124/jbisrir-2015-2213.
6
Prehospital Modified HEART Score Predictive of 30-Day Adverse Cardiac Events.院前改良HEART评分对30天不良心脏事件的预测作用
Prehosp Disaster Med. 2018 Feb;33(1):58-62. doi: 10.1017/S1049023X17007154. Epub 2018 Jan 10.
7
Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial.通过单次肌钙蛋白检测在院前排除非ST段抬高型急性冠状动脉综合征:ARTICA随机试验的一年最终结果
Eur Heart J Qual Care Clin Outcomes. 2024 Aug 8;10(5):411-420. doi: 10.1093/ehjqcco/qcae004.
8
Clinical utility of the HEART score in patients admitted with chest pain to an inner-city hospital in the USA.HEART评分在美国一家市中心医院胸痛入院患者中的临床应用价值。
Coron Artery Dis. 2017 Jun;28(4):336-341. doi: 10.1097/MCA.0000000000000474.
9
Pre-hospital evaluation of chest pain patients using the modified HEART-score: rationale and design.采用改良的 HEART 评分对胸痛患者进行院前评估:原理和设计。
Future Cardiol. 2024 Apr 25;20(5-6):241-250. doi: 10.1080/14796678.2024.2356995. Epub 2024 Jun 28.
10
Early Exclusion of Major Adverse Cardiac Events in Emergency Department Chest Pain Patients: A Prospective Observational Study.急诊科胸痛患者主要不良心脏事件的早期排除:一项前瞻性观察研究。
J Emerg Med. 2017 Sep;53(3):287-294. doi: 10.1016/j.jemermed.2017.05.006.

引用本文的文献

1
Adequately identifying low-risk chest pain in emergency primary care: evaluating the performance of preHEAR(T) based on two European cohorts.在急诊初级护理中充分识别低风险胸痛:基于两个欧洲队列评估preHEAR(T)的性能。
Open Heart. 2025 Jul 27;12(2):e003362. doi: 10.1136/openhrt-2025-003362.
2
Improving the accUracy of Referrals to the emerGency departmEnt of patieNts with chesT pain using the modified HEART score in Emergency Medical Transport (URGENT 2.0): protocol for a multicentre randomised controlled trial.在紧急医疗转运中使用改良HEART评分提高胸痛患者转诊至急诊科的准确性(URGENT 2.0):一项多中心随机对照试验方案
BMJ Open. 2024 Dec 20;14(12):e084139. doi: 10.1136/bmjopen-2024-084139.
3
Pre-hospital evaluation of chest pain patients using the modified HEART-score: rationale and design.
采用改良的 HEART 评分对胸痛患者进行院前评估:原理和设计。
Future Cardiol. 2024 Apr 25;20(5-6):241-250. doi: 10.1080/14796678.2024.2356995. Epub 2024 Jun 28.
4
AI Algorithm to Predict Acute Coronary Syndrome in Prehospital Cardiac Care: Retrospective Cohort Study.用于预测院前心脏护理中急性冠状动脉综合征的人工智能算法:回顾性队列研究。
JMIR Cardio. 2023 Oct 31;7:e51375. doi: 10.2196/51375.
5
Improved prehospital triage for acute cardiac care: results from HART-c, a multicentre prospective study.急性心脏护理的院前分诊改善:多中心前瞻性研究HART-c的结果
Neth Heart J. 2023 May;31(5):202-209. doi: 10.1007/s12471-023-01766-3. Epub 2023 Mar 29.
6
Applying the HEART score is safe and saves.应用HEART评分是安全且节省成本的。 (原英文表述似乎有误,推测正确表述可能是“Applying the HEART score is safe and cost-saving.”)
Neth Heart J. 2022 Jul;30(7-8):350-351. doi: 10.1007/s12471-022-01710-x. Epub 2022 Jul 5.
7
Novel Prehospital Phenotypes and Outcomes in Adult-Patients with Acute Disease.急性病成年患者的新型院前表型和结局。
J Med Syst. 2022 May 21;46(7):45. doi: 10.1007/s10916-022-01825-z.
8
Development and validation of a comprehensive early risk prediction model for patients with undifferentiated acute chest pain.未分化急性胸痛患者综合早期风险预测模型的开发与验证
Int J Cardiol Heart Vasc. 2022 Apr 28;40:101043. doi: 10.1016/j.ijcha.2022.101043. eCollection 2022 Jun.
9
Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis.院前疑似非 ST 段抬高型急性冠状动脉综合征患者的风险评估:系统评价和荟萃分析。
BMJ Open. 2022 Apr 5;12(4):e057305. doi: 10.1136/bmjopen-2021-057305.
10
Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.心血管病生物标志物的开发:回顾过去,展望未来。
Cells. 2022 Feb 8;11(3):588. doi: 10.3390/cells11030588.